Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

In 2005, men used finasteride mainly to treat an enlarged prostate.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Testosterone's muscle-building effects do not require its conversion to DHT.

Men with better urinary symptoms have a lower risk of death.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

The herbal combination of saw palmetto and stinging nettle reduces nighttime urination in men with urinary issues.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Finasteride increases hair count and improves hair growth with low risk of side effects.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

The market for these drugs is expected to grow.

Finasteride is mostly broken down in the body and excreted in urine and feces.

Topical finasteride may be safer than oral finasteride, but more research is needed.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Researchers developed a quick and accurate method to measure hormones in urine, confirming a baldness treatment's effectiveness without altering hormone levels.

The document's conclusion cannot be determined without content.

The DHT immunoassay is unreliable due to high cross-reactivity with testosterone.

Combining Minoxidil with topical Dutasteride via microneedling is the most effective and safe treatment for hair loss.